Legislative Advocacy

BioNTX advocates for policies designed to improve the business environment for the life science and healthcare innovation industries by encouraging investment in innovation and ensuring that legislation and regulation focus on timely, science-based, and patient-focused outcomes. We inform legislators to advance incentives that ensure the innovation economy in North Texas flourishes.

Find your Representatives

DOWNLOAD OUR TEMPLATE AND USE YOUR VOICE TO WRITE YOUR REPRESENTATIVES TODAY ON LEGISLATION THAT GREATLY AFFECTS OUR INDUSTRY!

Understanding who represents you in government is essential for advocating, influencing policy, and addressing regulatory, funding, and market access issues.Get involved in the political process, help shape the industry landscape, and contribute to innovation and public health promotion today!

2024 McDermottPlus Healthcare Policy Election Guide

As Election Day approaches on March 5, 2024, the McDermottPlus Election 2024 Resource Center stands as a vital hub for stakeholders, providing essential tools to comprehend and navigate the shifting landscape of healthcare policy during this pivotal election year. With analyses on key variables, insights into healthcare extenders, and comprehensive trackers for committee memberships and congressional retirements, it offers indispensable resources to anticipate and adapt to potential changes in the healthcare sector.

Federal Legislative News

Federal Level
NIH to increase pay levels for pre- and postdoctoral scholars at grantee institutions
NIH to increase pay levels for pre- and postdoctoral scholars at grantee institutions
Securing America's Biotech Leadership for National Security
Securing America's Biotech Leadership for National Security
Nurturing Trust in the Digital Age for Consumer Confidence
Nurturing Trust in the Digital Age for Consumer Confidence
AI's Influence on Gene Therapy: Optimizing Development for Success
AI's Influence on Gene Therapy: Optimizing Development for Success
Proposed Inflation Reduction Act Expansion Threatens U.S. Biopharma with Job Losses and Innovation Decline
Proposed Inflation Reduction Act Expansion Threatens U.S. Biopharma with Job Losses and Innovation Decline
The Impact of The House Proposed IRA Expansion on the US Biopharma Ecosystem
The Impact of The House Proposed IRA Expansion on the US Biopharma Ecosystem
Loss of Tax Incentive for R&D Threatens Biotech Innovation
Loss of Tax Incentive for R&D Threatens Biotech Innovation
Critical Path Institute Takes the Lead in Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases with New Task Force
Critical Path Institute Takes the Lead in Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases with New Task Force
ARPA-H Celebrates Official Launch of Investor Catalyst Hub
ARPA-H Celebrates Official Launch of Investor Catalyst Hub
NIH BRAIN Initiative Launches Projects to Develop Innovative Technologies to Map the Brain
NIH BRAIN Initiative Launches Projects to Develop Innovative Technologies to Map the Brain
ARPA-H Launches the CUREIT project to Develop New Tools to Strengthen the Immune System and Save Lives
ARPA-H Launches the CUREIT project to Develop New Tools to Strengthen the Immune System and Save Lives
NORD Announces More Than $100,000 in Grant Funding Available for Rare Disease Research
NORD Announces More Than $100,000 in Grant Funding Available for Rare Disease Research
What do you Know About the Inflation Reduction Act?
What do you Know About the Inflation Reduction Act?
What’s Next for Biopharma Under the Inflation Reduction Act
What’s Next for Biopharma Under the Inflation Reduction Act
Biden-Harris Administration Launches Initiative to Improve Cancer Outcomes in Low-Income Areas
Biden-Harris Administration Launches Initiative to Improve Cancer Outcomes in Low-Income Areas
Trends in the Approval of Cancer Therapies by the FDA in the 21st Century
Trends in the Approval of Cancer Therapies by the FDA in the 21st Century
FDA Launches Pilot Program to Help Reduce Risks Associated with Using Laboratory Developed Tests to Identify Cancer Biomarkers
FDA Launches Pilot Program to Help Reduce Risks Associated with Using Laboratory Developed Tests to Identify Cancer Biomarkers
Why Gene Therapies Must Go Virus-Free
Why Gene Therapies Must Go Virus-Free
FDA Announces Additional Steps to Modernize Clinical Trials
FDA Announces Additional Steps to Modernize Clinical Trials
Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products
Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products
Commerce Department Starts Process to Fund Tech Hubs Across the US with Grants
Commerce Department Starts Process to Fund Tech Hubs Across the US with Grants
NORD Rare Disease Centers of Excellence Expands to 40 US Medical Institutions
NORD Rare Disease Centers of Excellence Expands to 40 US Medical Institutions
FDA Approves First RSV Vaccine
FDA Approves First RSV Vaccine
New Biomarker, Suggests Potential Therapy For Multiple Sclerosis & Related Disorders
New Biomarker, Suggests Potential Therapy For Multiple Sclerosis & Related Disorders
Discovery Complex Movement Cortex Changes Iconic 'Homunculus' Diagram
Discovery Complex Movement Cortex Changes Iconic 'Homunculus' Diagram
FDA Panel Votes in Favor of Brexpiprazole as Potential Therapy for Alzheimer Agitation
FDA Panel Votes in Favor of Brexpiprazole as Potential Therapy for Alzheimer Agitation
FDA to Take Steps to Help Gene Therapies Get Accelerated Approval
FDA to Take Steps to Help Gene Therapies Get Accelerated Approval
ARPA-H is Open for Business
ARPA-H is Open for Business
ARPA-H Announces Strategy for Site Selection
ARPA-H Announces Strategy for Site Selection
FDA No Longer Needs To Require Animal Tests Before Human Drug Trials
FDA No Longer Needs To Require Animal Tests Before Human Drug Trials

State Legislative News

State Level
Dallas’ Federal Biotech Hub Targets First Mission: Untangling Clinical Trial Pipeline 
Dallas’ Federal Biotech Hub Targets First Mission: Untangling Clinical Trial Pipeline 
Read More →
Thank you Congressman Michael Burgess, MD for your Leadership in Healthcare in Texas
Thank you Congressman Michael Burgess, MD for your Leadership in Healthcare in Texas
Read More →
Texas Is Chosen for One of Three ARPA-H Hubs, with Dallas Snagging a Key Prize
Texas Is Chosen for One of Three ARPA-H Hubs, with Dallas Snagging a Key Prize
Read More →
Texas Becomes Latest State to Improve Access to Biomarker Testing
Texas Becomes Latest State to Improve Access to Biomarker Testing
Read More →
BioNTX Supports Texas Consortium For ARPA-H Customer Experience Hub
BioNTX Supports Texas Consortium For ARPA-H Customer Experience Hub
Read More →
Collaboration in the Lone Star State Invites ARPA-H Hub-Site to NTX
Collaboration in the Lone Star State Invites ARPA-H Hub-Site to NTX
Read More →
$3B Brain Research Bill Advances to Senate Vote
$3B Brain Research Bill Advances to Senate Vote
Read More →
Expand Access to Biomarker Testing in TX
Expand Access to Biomarker Testing in TX
Read More →
Mental Health and Brain Research Institute of Texas
Mental Health and Brain Research Institute of Texas
Read More →
BioNTX Testifies at the Texas Capitol in Support of HB15 / HJR 135
BioNTX Testifies at the Texas Capitol in Support of HB15 / HJR 135
Read More →
Texas Turns its Attention to Our Industry at the 88th Legislative Session in Austin
Texas Turns its Attention to Our Industry at the 88th Legislative Session in Austin
Read More →
NORD’s Texas Report Card for Rare Disease
NORD’s Texas Report Card for Rare Disease
Read More →
Texas Leads the Fight Against Cancer
Texas Leads the Fight Against Cancer
Read More →
Ernst & Young 2022 Beyond Borders Texas Report
Ernst & Young 2022 Beyond Borders Texas Report
Read More →
Coalition for Health Advancement and Research in Texas (CHART) and Texas Congressional Delegation supports ARPA-H to be in Texas
Coalition for Health Advancement and Research in Texas (CHART) and Texas Congressional Delegation supports ARPA-H to be in Texas
Read More →
Texas Eyes New Federal Biomedical Agency - ARPA-H
Texas Eyes New Federal Biomedical Agency - ARPA-H
Read More →

Critical Industry News